Literature DB >> 28417026

Cardiovascular Complications of Acute Amphetamine Abuse: Cross-sectional study.

Elham Bazmi1, Farinaz Mousavi1, Leila Giahchin1, Tahmineh Mokhtari2, Behnam Behnoush3.   

Abstract

OBJECTIVES: This study aimed to evaluate cardiovascular complications among patients who abuse amphetamines.
METHODS: This cross-sectional study took place between April 2014 and April 2015 among 3,870 patients referred to the Toxicology Emergency Department of Baharlou Hospital, Tehran University of Medical Sciences, Tehran, Iran. Those with clinical signs of drug abuse and positive urine screening tests were included in the study, while cases of chronic abuse were excluded. Cardiac complications were evaluated via electrocardiography (ECG) and transthoracic echocardiography.
RESULTS: A total of 230 patients (5.9%) had a history of acute amphetamine abuse and positive urine tests. Of these, 32 patients (13.9%) were <20 years old and 196 (85.2%) were male. In total, 119 (51.7%) used amphetamine and methamphetamine compounds while 111 (48.3%) used amphetamines with morphine or benzodiazepines. The most common ECG finding was sinus tachycardia (43.0%), followed by sinus tachycardia plus a prolonged QT interval (34.3%). Mean creatine kinase-MB and troponin I levels were 35.9 ± 4.3 U/mL and 0.6 ± 0.2 ng/mL, respectively. A total of 60 patients (26.1%) were admitted to the Intensive Care Unit. The majority (83.3%) of these patients had normal echocardiography results. The mean aortic root diameter (ARD) was 27.2 ± 2.8 mm. Abnormalities related to the ARD were found in 10 patients (16.7%), three of whom subsequently died.
CONCLUSION: According to these findings, cardiac complications were common among Iranian patients who abuse amphetamines, although the majority of patients had normal echocardiography and ECG findings.

Entities:  

Keywords:  Amphetamines; Cardiovascular Abnormalities; Echocardiography; Electrocardiography; Iran; Substance Abuse; Tachycardia

Mesh:

Substances:

Year:  2017        PMID: 28417026      PMCID: PMC5380419          DOI: 10.18295/squmj.2016.17.01.007

Source DB:  PubMed          Journal:  Sultan Qaboos Univ Med J        ISSN: 2075-051X


  28 in total

1.  The normal Q-T interval.

Authors:  E SIMONSON; L D CADY; M WOODBURY
Journal:  Am Heart J       Date:  1962-06       Impact factor: 4.749

Review 2.  Sex differences in drug abuse.

Authors:  Jill B Becker; Ming Hu
Journal:  Front Neuroendocrinol       Date:  2007-08-24       Impact factor: 8.606

3.  The association of methamphetamine use and cardiomyopathy in young patients.

Authors:  Khung-Keong Yeo; Mevan Wijetunga; Hiroki Ito; Jimmy T Efird; Kevin Tay; Todd B Seto; Kavitha Alimineti; Chieko Kimata; Irwin J Schatz
Journal:  Am J Med       Date:  2007-02       Impact factor: 4.965

4.  Cardiovascular responses elicited by the "binge" administration of methamphetamine.

Authors:  Kurt J Varner; Brian A Ogden; Joseph Delcarpio; Suzanne Meleg-Smith
Journal:  J Pharmacol Exp Ther       Date:  2002-04       Impact factor: 4.030

5.  Prevalence and risk factors of ecstasy use among college students in Astara, Islamic Republic of Iran.

Authors:  Z Mohtasham Amiri; A Jafari Shakib; A Khalili Moosavi
Journal:  East Mediterr Health J       Date:  2009 Sep-Oct       Impact factor: 1.628

Review 6.  Substance abuse among Iranian high school students.

Authors:  Saeed Momtazi; Richard Rawson
Journal:  Curr Opin Psychiatry       Date:  2010-05       Impact factor: 4.741

7.  High mortality rates among GHB abusers in Western Sweden.

Authors:  Kai Knudsen; Joachim Greter; Mario Verdicchio
Journal:  Clin Toxicol (Phila)       Date:  2008-03       Impact factor: 4.467

8.  Acute myocardial infarction in young adults who abuse amphetamines.

Authors:  Arthur N Westover; Paul A Nakonezny; Robert W Haley
Journal:  Drug Alcohol Depend       Date:  2008-03-19       Impact factor: 4.492

9.  Crystal methamphetamine-associated cardiomyopathy: tip of the iceberg?

Authors:  Mevan Wijetunga; Todd Seto; Joseph Lindsay; Irwin Schatz
Journal:  J Toxicol Clin Toxicol       Date:  2003

Review 10.  The methamphetamine problem in the United States.

Authors:  Rachel Gonzales; Larissa Mooney; Richard A Rawson
Journal:  Annu Rev Public Health       Date:  2010       Impact factor: 21.981

View more
  5 in total

Review 1.  Stimulant Drugs of Abuse and Cardiac Arrhythmias.

Authors:  Paari Dominic; Javaria Ahmad; Hajra Awwab; Md Shenuarin Bhuiyan; Christopher G Kevil; Nicholas E Goeders; Kevin S Murnane; James C Patterson; Kristin E Sandau; Rakesh Gopinathannair; Brian Olshansky
Journal:  Circ Arrhythm Electrophysiol       Date:  2021-12-28

2.  Correlation between loneliness, personality traits, and treatment outcomes in patients with methamphetamine use disorder.

Authors:  Tsung-Yu Tsai; Tzu-Yun Wang; Huai-Hsuan Tseng; Kao Chin Chen; Ching-Ju Chiu; Po See Chen; Yen Kuang Yang
Journal:  Sci Rep       Date:  2022-05-23       Impact factor: 4.996

3.  Potential Role of Serum S-100β Protein as a Predictor of Cardiotoxicity and Clinical Poor Outcome in Acute Amphetamine Intoxication.

Authors:  Asmaa F Sharif; Eman Elsheikh; Abdullah Z Al-Asmari; Dina El Gameel
Journal:  Cardiovasc Toxicol       Date:  2021-01-09       Impact factor: 3.231

4.  Serum Metabolomic Analysis of Male Patients with Cannabis or Amphetamine Use Disorder.

Authors:  Fawaz Alasmari; Mohammed A Assiri; Syed Rizwan Ahamad; Sahar R Aljumayi; Wedad H Alotaibi; Majd M Alhamdan; Khalid Alhazzani; Metab Alharbi; Faleh Alqahtani; Abdullah F Alasmari
Journal:  Metabolites       Date:  2022-02-14

Review 5.  Clinical Characteristics and Management of Methamphetamine-Associated Cardiomyopathy: State-of-the-Art Review.

Authors:  Pavan K V Reddy; Tien M H Ng; Esther E Oh; Gassan Moady; Uri Elkayam
Journal:  J Am Heart Assoc       Date:  2020-05-29       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.